Medication Use and the Risk of Newly Diagnosed Diabetes in Patients with Epilepsy: A Data Mining Application on a Healthcare Database

[1]  D. Thurman,et al.  Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: A US database analysis , 2018, Epilepsy & Behavior.

[2]  Yong Hu,et al.  Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports , 2017, Artif. Intell. Medicine.

[3]  Hung-Wen Chiu,et al.  Comorbidity study of ADHD: Applying association rule mining (ARM) to National Health Insurance Database of Taiwan , 2009, Int. J. Medical Informatics.

[4]  Josemir W Sander,et al.  Comorbidities of epilepsy: current concepts and future perspectives , 2016, The Lancet Neurology.

[5]  Wynne Hsu,et al.  Pruning and summarizing the discovered associations , 1999, KDD '99.

[6]  J. Hallas,et al.  Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations. , 2018, Basic & Clinical Pharmacology & Toxicology.

[7]  P. Waller.  Making the most of spontaneous adverse drug reaction reporting. , 2006, Basic & clinical pharmacology & toxicology.

[8]  Cheng-Hsien Lu,et al.  Effects of long‐term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis , 2012, Epilepsia.

[9]  S. Larif,et al.  Drug-Induced Hyperglycaemia and Diabetes , 2015, Drug Safety.

[10]  J. Gagne,et al.  Hypothesis-free screening of large administrative databases for unsuspected drug-outcome associations , 2018, European Journal of Epidemiology.

[11]  F. Chiarelli,et al.  The metabolic syndrome in overweight epileptic patients treated with valproic acid , 2010, Epilepsia.

[12]  Rajeev Motwani,et al.  Dynamic itemset counting and implication rules for market basket data , 1997, SIGMOD '97.

[13]  Pau-Chung Chen,et al.  Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study , 2017, PloS one.

[14]  Swu-Jane Lin,et al.  Comparative stroke risk of antiepileptic drugs in patients with epilepsy , 2013, Epilepsia.

[15]  R. Altman,et al.  Detecting Drug Interactions From Adverse‐Event Reports: Interaction Between Paroxetine and Pravastatin Increases Blood Glucose Levels , 2011, Clinical pharmacology and therapeutics.

[16]  H. Omar,et al.  Seizure as the first presentation of diabetes mellitus , 2012, Therapeutic Advances in Endocrinology and Metabolism.

[17]  J. French,et al.  Treatment of epilepsy in adults. , 2016, Epileptic disorders : international epilepsy journal with videotape.

[18]  Jiawei Han,et al.  Knowledge Discovery in Databases: An Attribute-Oriented Approach , 1992, VLDB.

[19]  M. Brodie,et al.  Enzyme induction with antiepileptic drugs: Cause for concern? , 2013, Epilepsia.

[20]  E. Ryan,et al.  Phenytoin‐induced Insulin Insensitivity , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[21]  Philippe Ryvlin,et al.  Epilepsy: new advances , 2015, The Lancet.

[22]  H. Koh,et al.  Data mining applications in healthcare. , 2005, Journal of healthcare information management : JHIM.

[23]  Jiawei Han,et al.  Frequent pattern mining: current status and future directions , 2007, Data Mining and Knowledge Discovery.

[24]  D. Ekstein,et al.  Concomitant therapy in people with epilepsy: Potential drug–drug interactions and patient awareness , 2014, Epilepsy & Behavior.

[25]  S. Kõks,et al.  Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine , 2016, Seizure.

[26]  I. Idris,et al.  Drug‐Induced Diabetes Mellitus: Evidence for Statins and Other Drugs Affecting Glucose Metabolism , 2016, Clinical pharmacology and therapeutics.

[27]  A. Sharaf Eldin,et al.  Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data , 2016, J. Biomed. Informatics.

[28]  Ramakrishnan Srikant,et al.  Mining generalized association rules , 1995, Future Gener. Comput. Syst..

[29]  Minal Vanarse,et al.  MULTILEVEL ASSOCIATION RULE MINING FOR LARGE DATASETS: A REVIEW , 2017 .

[30]  Jiawei Han,et al.  Discovery of Multiple-Level Association Rules from Large Databases , 1995, VLDB.

[31]  Tomasz Imielinski,et al.  Mining association rules between sets of items in large databases , 1993, SIGMOD Conference.

[32]  Ya-Han Hu,et al.  Comorbidity study of borderline personality disorder: applying association rule mining to the Taiwan national health insurance research database , 2017, BMC Medical Informatics and Decision Making.

[33]  Illhoi Yoo,et al.  Data Mining in Healthcare and Biomedicine: A Survey of the Literature , 2012, Journal of Medical Systems.

[34]  Wynne Hsu,et al.  Integrating Classification and Association Rule Mining , 1998, KDD.

[35]  S. Guler.  Development of Insulin Resistance in Patients with Epilepsy During Valproate and Carbamazepine Monotherapy , 2016 .

[36]  G. Papazisis,et al.  Detecting a potential safety signal of antidepressants and type 2 diabetes: a pharmacovigilance‐pharmacodynamic study , 2018, British journal of clinical pharmacology.

[37]  Rajeev Motwani,et al.  Beyond market baskets: generalizing association rules to correlations , 1997, SIGMOD '97.

[38]  G. Krauss,et al.  Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study , 2018, JAMA neurology.

[39]  Swu-Jane Lin,et al.  Use of antiepileptic drugs and risk of hypothyroidism , 2013, Pharmacoepidemiology and drug safety.

[40]  Swu-Jane Lin,et al.  Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study , 2016, Medicine.

[41]  Chung-Yi Li,et al.  Validation of algorithms to identify stroke risk factors in patients with acute ischemic stroke, transient ischemic attack, or intracerebral hemorrhage in an administrative claims database. , 2016, International journal of cardiology.

[42]  J. Montastruc,et al.  Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological–Pharmacodynamic Study in VigiBase® , 2018, Drug Safety.

[43]  C. Lutcher,et al.  Diphenylhydantoin-induced Hyperglycemia and Impaired Insulin Release: Effect of Dosage , 1971, Diabetes.